Abstract:A crucial step for tumor cell extravasation and metastasis is the migration through the extracellular matrix, which requires proteolytic activity. Hence, proteases, particularly matrix metalloproteases (MMPs), have been discussed as therapeutic targets and their inhibition should diminish tumor growth and metastasis. The metalloproteases meprin α and meprin β are highly abundant on intestinal enterocytes and their expression was associated with different stages of colorectal cancer. Due to their ability to cleave extracellular matrix (ECM) components, they were suggested as pro-tumorigenic enzymes. Additionally, both meprins were shown to have pro-inflammatory activity by cleaving cytokines and their receptors, which correlates with chronic intestinal inflammation and associated conditions. On the other hand, meprin β was identified as an essential enzyme for the detachment and renewal of the intestinal mucus, important to prevent bacterial overgrowth and infection. Considering this, it is hard to estimate whether high activity of meprins is generally detrimental or if these enzymes have also protective functions in certain cancer types. For instance, for colorectal cancer, patients with high meprin β expression in tumor tissue exhibit a better survival prognosis, which is completely different to prostate cancer. This demonstrates that the very same enzyme may have contrary effects on tumor initiation and growth, depending on its tissue and subcellular localization. Hence, precise knowledge about proteolytic enzymes is required to design the most efficient therapeutic options for cancer treatment. In this review, we summarize the current findings on meprins' functions, expression, and cancer-associated variants with possible implications for tumor progression and metastasis.

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

MMP Enzyme in Tumor Micro-environment: A Promising Target for Nano-medicine Delivery

The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2

Matrix metalloproteinases involvement in pathologic conditions

Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

Matrix metalloproteinases at a glance

Matrix Metalloproteinases: New Targets in Cancer Therapy

Matrix metalloproteases: variations on a theme

Progress in Study of Matrix Metalloproteinases and Tumour Invasion and Metastasis

Metalloproteinases in Ovarian Cancer

Role of meprin metalloproteases in metastasis and tumor microenvironment

Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs

Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling

Role of Integrins in Regulating Proteases to Mediate Extracellular Matrix Remodeling

The paradoxical role of matrix metalloproteinase-11 in cancer

Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair

The Functional Role of Extracellular Matrix Proteins in Cancer

The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance

The extracellular matrix modulates the hallmarks of cancer